DMRA Damora Therapeutics, Inc.
Healthcare · Market cap: $1.3B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $42.3K | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $471.6K |
| 2023-Q3 | $0 | $1.8M |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $11.6K |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $3.9K |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $23.3K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $252.9K | $7.3K |
| 2026-Q4 | $0 | $0 |
Bought$310.1K5 buy days
Sold$2.3M22 sell days
Net insider flow-$2.0Mnet selling · 5 years
Latest trade2026-09-25Jarrett Jennifer
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Buy | Jarrett Jennifer | CEO | 12,500 | $20.23 | $252.9K | 1 |
| 2026-07-06 | Sell | Winslow Garrett | General counsel | 245 | $29.98 | $7.3K | 1 |
| 2026-01-02 | Sell | Schambye Hans T. | CEO | 700 | $21.38 | $15.0K | 1 |
| 2026-01-02 | Sell | Winslow Garrett | General counsel | 255 | $21.38 | $5.5K | 1 |
| 2026-01-02 | Sell | Firmani Lori | CFO | 135 | $21.41 | $2.9K | 1 |
| 2025-07-03 | Sell | Schambye Hans T. | CEO | 735 | $3.38 | $2.5K | 1 |
| 2025-07-03 | Sell | Winslow Garrett | General counsel | 260 | $3.39 | $881 | 1 |
| 2025-07-03 | Sell | Firmani Lori | CFO | 147 | $3.39 | $498 | 1 |
| 2025-01-03 | Sell | Schambye Hans T. | CEO | 1,341 | $5.60 | $7.5K | 1 |
| 2025-01-03 | Sell | Winslow Garrett | General counsel | 471 | $5.60 | $2.6K | 1 |
| 2025-01-03 | Sell | Firmani Lori | CFO | 261 | $5.63 | $1.5K | 1 |
| 2023-08-15 | Sell | ORBIMED ADVISORS LLC | 10% owner | 822,680 | $0.75 | $617.0K | 3 |
| 2023-07-31 | Sell | ORBIMED ADVISORS LLC | 10% owner | 209,400 | $3.00 | $628.2K | 3 |
| 2023-07-25 | Sell | ORBIMED ADVISORS LLC | 10% owner | 39,200 | $2.92 | $114.5K | 3 |
| 2023-07-13 | Sell | ORBIMED ADVISORS LLC | 10% owner | 194,700 | $2.40 | $467.3K | 3 |
| 2023-04-17 | Sell | ORBIMED ADVISORS LLC | 10% owner | 13,089 | $1.97 | $25.8K | 3 |
| 2023-04-14 | Sell | ORBIMED ADVISORS LLC | 10% owner | 41,446 | $1.86 | $77.1K | 3 |
| 2023-04-13 | Sell | ORBIMED ADVISORS LLC | 10% owner | 13,946 | $1.82 | $25.4K | 3 |
| 2023-04-12 | Sell | ORBIMED ADVISORS LLC | 10% owner | 2,363 | $1.81 | $4.3K | 3 |
| 2023-04-11 | Sell | ORBIMED ADVISORS LLC | 10% owner | 13,946 | $1.82 | $25.4K | 3 |
| 2023-04-10 | Sell | ORBIMED ADVISORS LLC | 10% owner | 51,228 | $1.79 | $91.7K | 3 |
| 2023-04-06 | Sell | ORBIMED ADVISORS LLC | 10% owner | 9,665 | $2.00 | $19.3K | 3 |
| 2023-04-05 | Sell | ORBIMED ADVISORS LLC | 10% owner | 92,965 | $2.18 | $202.7K | 3 |
| 2022-03-22 | Buy | Lindmark Bertil | Other C-suite | 14,604 | $2.16 | $31.5K | 1 |
| 2022-03-22 | Buy | Schambye Hans T. | CEO | 5,000 | $2.15 | $10.8K | 1 |
| 2021-12-03 | Buy | Freve Jonathan | CFO | 4,000 | $2.49 | $10.0K | 1 |
| 2021-12-03 | Buy | Winslow Garrett | General counsel | 2,000 | $2.48 | $5.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% owner | $0 | $2.3M | 2023-08-15 |
| Jarrett Jennifer | CEO | $252.9K | $0 | 2026-09-25 |
| Schambye Hans T. | CEO | $10.8K | $25.0K | 2026-01-02 |
| Lindmark Bertil | Other C-suite | $31.5K | $0 | 2022-03-22 |
| Winslow Garrett | General counsel | $5.0K | $16.3K | 2026-07-06 |
| Freve Jonathan | CFO | $10.0K | $0 | 2021-12-03 |
| Firmani Lori | CFO | $0 | $4.9K | 2026-01-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2021-11-08 → 2021-12-03 | 3 | $40.9K | 45 | +19.2% (+19.8% raw) | -16.0% (-25.8% raw) | -1.7% (-13.1% raw) | closed |
| 2021-06-23 → 2021-06-28 | 4 | $44.9K | 51 | -15.2% (-21.5% raw) | – | -35.2% (-39.1% raw) | closed |
| 2020-11-02 | 4 | $28.0M | 46 | -8.5% (-2.8% raw) | -30.0% (-17.7% raw) | -85.1% (-64.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.